Patients with Niemann-Pick disease type C who received N-acetyl-L-leucine (NALL), an agent that potentially ameliorates lysosomal and metabolic dysfunction, showed reduced neurologic signs and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback